Cargando…
Recombinant activated factor VII in controlling bleeding in non-hemophiliac patients
BACKGROUND: There have been recent reports on the successful use of recombinant factor VIIa (rFVIIa) in non-hemophiliac patients who have experienced heavy blood loss due to trauma with extensive organ damage and who have received multiple blood transfusions with hemostatic changes without success....
Autores principales: | AlGahtani, Farjah H., Alshaikh, Mashael, AlDiab, AbdulRehman |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886869/ https://www.ncbi.nlm.nih.gov/pubmed/20427935 http://dx.doi.org/10.4103/0256-4947.62830 |
Ejemplares similares
-
Bleeding Diathesis as the Initial Presentation of Chronic Myeloid Leukemia: A Case Series
por: AlGahtani, Farjah H, et al.
Publicado: (2023) -
Secondary hemosiderosis presented by porphyria cutanea tarda in a
kidney dialysis patient: A case report
por: AlGahtani, Farjah H, et al.
Publicado: (2020) -
Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery
por: Habib, Aly Makram, et al.
Publicado: (2016) -
Congenital Bleeding Disorders: Managing Central Nervous System Bleeding in an Adult Hemophiliac
por: Dahra, Anurag, et al.
Publicado: (2023) -
Recombinant-activated factor VII in patients with uncontrolled bleeding: A retrospective observational analysis
por: Abuhasna, Said D., et al.
Publicado: (2012)